Health issues touch us all, both personally and through loved ones. At inVita intelligence, we know that being able to advocate for yourself or those you care for has never been more important to achieving better health outcomes.
Decades of experience at some of the largest players in global healthcare, combined with our personal experiences ensure we are focused on reshaping healthcare through personalised, actionable information and health solutions.
We originally achieved this by creating INRstar and Engage – market leading software that connects patients remotely with clinicians for complete anticoagulation management and making life better for everyone involved.
Today, we are turning that same approach to heart failure and other long-term conditions, that are some of the most pressing health challenges.
We didn't start with a vision statement. We started with a problem: anticoagulation management was getting more complex, and clinicians needed better support around dosing, testing, compliance and reporting. INRstar was built to support better decisions and improve outcomes for patients. Everything since has followed the same idea. If the technology doesn't make life genuinely better for the patient, it's not good enough.
We launch our first dedicated anticoagulation clinical decision support system, transforming how NHS services manage warfarin patients, bringing care closer to home.
INRstar® grows to support over 2,400 anticoagulation services across the UK and Ireland, becoming the trusted standard for clinical decision support in the specialty.
With a bold new vision: take everything we've learned from 25 years in healthcare and technology, to build a leading health technology company.
Launch of our Digital health companion, a platform for long-term condition self-management, starting with heart failure. Validated with patients, heart failure teams and charities.
We launch iVAi® Beat, our wearable heart health monitor, while our Digital health companion expands from heart failure into other long-term conditions.
Whether you're a patient, a clinician or a potential partner, we'd love to hear from you.